Boswellia

Boswellia, Indian Frankincense

The dry extract obtained from the gum-resin from Boswellia tree is a powerfull antiinflamatory, used for the treatment of rheumatoid arthritis, inflammatory processes, inflammation and arthritic conditions, osteoarthritis, juvenile rheumatoid arthritis, myositis and fibrositis and colitis.

Nutraceutic

  • Origin Plant Based
  • Source Itself
  • Type Bioactive Compounds

Bone and Joint Health

Bones and joints support the body and muscles, which make you move. They also take an important part in controlling vitamins, hormones and minerals, such as calcium, vitamin D and thyroid hormones. Supplements that affect bone and joint health help their structure and strength, in addition to contributing to the healthy balance of involved components.
  • Symptoms of Osteoarthritis

    Osteoarthritis is a very common chronic condition among the elderly that incompasses bones and cartilage. Symptoms include joint pain in the hands, neck, lower back, knees or hips, as well as movement difficultness.
  • Age Range Adults (20-59)
  • Toxicity May be toxic in high doses
  • Side effects Skin Rashes
  • Warnings Allergics

Why be Careful

References

  1. a b Tawab MA, et al. Development of a high-performance liquid chromatographic method for the determination of 11-keto-beta-boswellic acid in human plasmaJ Chromatogr B Biomed Sci Appl. (2001)
  2. ^ Woolley CL, et al. Chemical differentiation of Boswellia sacra and Boswellia carterii essential oils by gas chromatography and chiral gas chromatography-mass spectrometryJ Chromatogr A. (2012)
  3. ^ de Rapper S, et al. The additive and synergistic antimicrobial effects of select frankincense and myrrh oils–a combination from the pharaonic pharmacopoeiaLett Appl Microbiol. (2012)
  4. ^ Blain EJ, Ali AY, Duance VC. Boswellia frereana (frankincense) suppresses cytokine-induced matrix metalloproteinase expression and production of pro-inflammatory molecules in articular cartilagePhytother Res. (2010)
  5. ^ Devi PR, et al. Safety Evaluation of Alcoholic Extract of Boswellia ovalifoliolata Stem-bark in RatsToxicol Int. (2012)
  6. a b c Siddiqui MZ. Boswellia serrata, a potential antiinflammatory agent: an overviewIndian J Pharm Sci. (2011)
  7. a b c d e f g h Gerbeth K, et al. Determination of major boswellic acids in plasma by high-pressure liquid chromatography/mass spectrometryJ Pharm Biomed Anal. (2011)
  8. a b c d e f g h i j k l Moussaieff A, et al. Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brainFASEB J. (2008)
  9. ^ Al-Harrasi A, Al-Saidi S. Phytochemical analysis of the essential oil from botanically certified oleogum resin of Boswellia sacra (Omani Luban)Molecules. (2008)
  10. a b Wang C, et al. Determination of five boswellic acids in Boswellia serrataZhongguo Zhong Yao Za Zhi. (2011)
  11. a b c Büchele B, Simmet T. Analysis of 12 different pentacyclic triterpenic acids from frankincense in human plasma by high-performance liquid chromatography and photodiode array detectionJ Chromatogr B Analyt Technol Biomed Life Sci. (2003)
  12. a b c d e f g h Moussaieff A, et al. Incensole acetate reduces depressive-like behavior and modulates hippocampal BDNF and CRF expression of submissive animalsJ Psychopharmacol. (2012)
  13. ^ Paul M, Jauch J. Efficient preparation of incensole and incensole acetate, and quantification of these bioactive diterpenes in Boswellia papyrifera by a RP-DAD-HPLC methodNat Prod Commun. (2012)
  14. a b c Bhushan S, et al. A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cellsApoptosis. (2007)
  15. a b c Bhushan S, et al. Activation of p53/p21/PUMA alliance and disruption of PI-3/Akt in multimodal targeting of apoptotic signaling cascades in cervical cancer cells by a pentacyclic triterpenediol from Boswellia serrataMol Carcinog. (2009)
  16. ^ Schmidt TJ, Kaiser M, Brun R. Complete structural assignment of serratol, a cembrane-type diterpene from Boswellia serrata, and evaluation of its antiprotozoal activityPlanta Med. (2011)
  17. ^ Two triterpenoids from Boswellia serrata gum resin.
  18. ^ TETRACYCLIC TRITERPENE ACIDS FROM RESIN OF BOSWELLIA-SERRATA ROXB.
  19. ^ Song Z, et al. Determination of alpha-pinene and octyl acetate contents in Boswellia serrataZhongguo Zhong Yao Za Zhi. (2012)
  20. a b c d e f Khajuria A, et al. Immunomodulatory activity of biopolymeric fraction BOS 2000 from Boswellia serrataPhytother Res. (2008)
  21. ^ The structure of incensole.
  22. a b c d Roy S, et al. Regulation of vascular responses to inflammation: inducible matrix metalloproteinase-3 expression in human microvascular endothelial cells is sensitive to antiinflammatory BoswelliaAntioxid Redox Signal. (2006)
  23. ^ Sengupta K, et al. Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extractMol Cell Biochem. (2011)
  24. a b c d e f g Takada Y, et al. Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expressionJ Immunol. (2006)
  25. ^ Kumar A, et al. Nuclear factor-kappaB: its role in health and diseaseJ Mol Med (Berl). (2004)
  26. ^ Ozes ON, et al. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinaseNature. (1999)
  27. ^ Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzleCell. (2002)
  28. ^ Nakayama T, Sawada T. Involvement of microtubule integrity in memory impairment caused by colchicinePharmacol Biochem Behav. (2002)
  29. ^ Trojanowski JQ, et al. Microtubule-stabilising drugs for therapy of Alzheimer’s disease and other neurodegenerative disorders with axonal transport impairmentsExpert Opin Pharmacother. (2005)
  30. ^ Nelson R. Microtubule-stabilising drugs may be therapeutic in ADLancet Neurol. (2005)
  31. ^ Avila J, et al. Role of tau protein in both physiological and pathological conditionsPhysiol Rev. (2004)
  32. a b Karima O, et al. An in vitro study of the role of β-boswellic acid in the microtubule assembly dynamicsFEBS Lett. (2012)
  33. a b Karima O, et al. The enhancement effect of beta-boswellic acid on hippocampal neurites outgrowth and branching (an in vitro study)Neurol Sci. (2010)
  34. ^ Krüger P, et al. Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2Eur J Pharm Sci. (2009)
  35. ^ Krishna G, et al. Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2Int J Pharm. (2001)
  36. a b c d e f g h Gerbeth K, et al. In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resinsFitoterapia. (2012)
  37. a b c d e f g h i Hüsch J, et al. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome®) of Boswellia extractFitoterapia. (2012)
  38. ^ Hüsch J, et al. Effect of Phospholipid-Based Formulations of Boswellia serrata Extract on the Solubility, Permeability, and Absorption of the Individual Boswellic Acid Constituents PresentJ Nat Prod. (2012)
  39. ^ Sharma A, Gupta NK, Dixit VK. Complexation with phosphatidyl choline as a strategy for absorption enhancement of boswellic acidDrug Deliv. (2010)
  40. a b c Reising K, et al. Determination of boswellic acids in brain and plasma by high-performance liquid chromatography/tandem mass spectrometryAnal Chem. (2005)
  41. a b c Tausch L, et al. Identification of human cathepsin G as a functional target of boswellic acids from the anti-inflammatory remedy frankincenseJ Immunol. (2009)
  42. ^ Sterk V, Büchele B, Simmet T. Effect of food intake on the bioavailability of boswellic acids from a herbal preparation in healthy volunteersPlanta Med. (2004)
  43. a b c d Skarke C, et al. Increased bioavailability of 11-keto-β-boswellic acid following single oral dose frankincense extract administration after a standardized meal in healthy male volunteers: modeling and simulation considerations for evaluating drug exposuresJ Clin Pharmacol. (2012)
  44. a b Siemoneit U, et al. On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevanceEur J Pharmacol. (2009)
  45. ^ Krüger P, et al. Metabolism of boswellic acids in vitro and in vivoDrug Metab Dispos. (2008)
  46. ^ Weber CC, et al. Modulation of Pgp function by boswellic acidsPlanta Med. (2006)
  47. ^ Chung MK, et al. TRPV3 and TRPV4 mediate warmth-evoked currents in primary mouse keratinocytesJ Biol Chem. (2004)
  48. ^ Xu H, et al. TRPV3 is a calcium-permeable temperature-sensitive cation channelNature. (2002)
  49. ^ Smith GD, et al. TRPV3 is a temperature-sensitive vanilloid receptor-like proteinNature. (2002)
  50. a b Bakthira H, et al. Anticholinesterase activity of endemic plant extracts from SoqotraAfr J Tradit Complement Altern Med. (2011)
  51. a b c Moussaieff A, et al. Protective effects of incensole acetate on cerebral ischemic injuryBrain Res. (2012)
  52. a b c Streffer JR, et al. Response of radiochemotherapy-associated cerebral edema to a phytotherapeutic agent, H15Neurology. (2001)
  53. a b c Winking M, et al. Boswellic acids inhibit glioma growth: a new treatment optionJ Neurooncol. (2000)
  54. ^ Lampl C, Haider B, Schweiger C. Long-term efficacy of Boswellia serrata in four patients with chronic cluster headacheCephalalgia. (2012)
  55. ^ Leroux E, Ducros A. Cluster headacheOrphanet J Rare Dis. (2008)
  56. a b Mahmoudi A, et al. Evaluation of systemic administration of Boswellia papyrifera extracts on spatial memory retention in male ratsJ Nat Med. (2011)
  57. ^ Roy S, et al. Human genome screen to identify the genetic basis of the anti-inflammatory effects of Boswellia in microvascular endothelial cellsDNA Cell Biol. (2005)
  58. a b c Cuaz-Pérolin C, et al. Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- miceArterioscler Thromb Vasc Biol. (2008)
  59. a b c d e f g h Sengupta K, et al. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical studyInt J Med Sci. (2010)
  60. ^ The IκB Kinase (IKK) Inhibitor, NEMO-binding Domain Peptide, Blocks Osteoclastogenesis and Bone Erosion in Inflammatory Arthritis.
  61. ^ Abu-Amer Y, Tondravi MM. NF-kappaB and bone: the breaking pointNat Med. (1997)
  62. ^ Kulkarni RR, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over studyJ Ethnopharmacol. (1991)
  63. ^ Chopra A, et al. Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritisJ Rheumatol. (2000)
  64. a b Vishal AA, Mishra A, Raychaudhuri SP. A double blind, randomized, placebo controlled clinical study evaluates the early efficacy of aflapin in subjects with osteoarthritis of kneeInt J Med Sci. (2011)
  65. a b Sengupta K, et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the kneeArthritis Res Ther. (2008)
  66. a b Gupta PK, et al. Clinical evaluation of Boswellia serrata (Shallaki) resin in the management of Sandhivata (osteoarthritis)Ayu. (2011)
  67. ^ Chrubasik JE, Roufogalis BD, Chrubasik S. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back painPhytother Res. (2007)
  68. ^ Cassileth B. Complementary therapies, herbs, and other OTC agents: Boswellia (Boswellia serrata)Oncology (Williston Park). (2009)
  69. ^ Martínez-Clemente M, Clària J, Titos E. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver diseaseCurr Opin Clin Nutr Metab Care. (2011)
  70. ^ Gupta I, et al. Effects of Boswellia serrata gum resin in patients with ulcerative colitisEur J Med Res. (1997)
  71. a b Sailer ER, et al. Acetyl-11-keto-beta-boswellic acid (AKBA): structure requirements for binding and 5-lipoxygenase inhibitory activityBr J Pharmacol. (1996)
  72. ^ Safayhi H, et al. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenaseJ Pharmacol Exp Ther. (1992)
  73. ^ Safayhi H, Sailer ER, Ammon HP. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acidMol Pharmacol. (1995)
  74. ^ Ammon HP, et al. Mechanism of antiinflammatory actions of curcumine and boswellic acidsJ Ethnopharmacol. (1993)
  75. ^ Siemoneit U, et al. Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acidsBiochem Pharmacol. (2008)
  76. a b c d Ammon HP. Modulation of the immune system by Boswellia serrata extracts and boswellic acidsPhytomedicine. (2010)
  77. ^ Poeckel D, Werz O. Boswellic acids: biological actions and molecular targetsCurr Med Chem. (2006)
  78. ^ Inhibition of IκB Kinase Activity by Acetyl-boswellic Acids Promotes Apoptosis in Androgen-independent PC-3 Prostate Cancer Cells in Vitro and in Vivo.
  79. a b Acetyl-Boswellic Acids Inhibit Lipopolysaccharide-Mediated TNF-α Induction in Monocytes by Direct Interaction with IκB Kinases.
  80. a b c d e Henkel A, et al. Boswellic acids from frankincense inhibit lipopolysaccharide functionality through direct molecular interferenceBiochem Pharmacol. (2012)
  81. ^ Morrison DC, Jacobs DM. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharidesImmunochemistry. (1976)
  82. ^ Moussaieff A, et al. Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activationMol Pharmacol. (2007)
  83. ^ Pham CT. Neutrophil serine proteases: specific regulators of inflammationNat Rev Immunol. (2006)
  84. a b Siemoneit U, et al. Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincenseBr J Pharmacol. (2011)
  85. ^ Samuelsson B, Morgenstern R, Jakobsson PJ. Membrane prostaglandin E synthase-1: a novel therapeutic targetPharmacol Rev. (2007)
  86. ^ Verhoff M, et al. A novel C(28)-hydroxylated lupeolic acid suppresses the biosynthesis of eicosanoids through inhibition of cytosolic phospholipase A(2)Biochem Pharmacol. (2012)
  87. a b c Safayhi H, et al. Inhibition by boswellic acids of human leukocyte elastaseJ Pharmacol Exp Ther. (1997)
  88. a b Kapil A, Moza N. Anticomplementary activity of boswellic acids–an inhibitor of C3-convertase of the classical complement pathwayInt J Immunopharmacol. (1992)
  89. a b c d e Immunomodulatory Activity of Boswellic Acids (Pentacyclic Triterpene Acids) from Boswellia serrata.
  90. ^ Khajuria A, et al. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAgVaccine. (2007)
  91. a b Immunomodulatory Triterpenoids from the Oleogum Resin of Boswellia carterii Birdwood.
  92. a b Shehata AM, et al. Prevention of multiple low-dose streptozotocin (MLD-STZ) diabetes in mice by an extract from gum resin of Boswellia serrata (BE)Phytomedicine. (2011)
  93. a b c d e Yuan HQ, et al. Inhibitory effect of acetyl-11-keto-beta-boswellic acid on androgen receptor by interference of Sp1 binding activity in prostate cancer cellsBiochem Pharmacol. (2008)
  94. ^ Rollinger JM, et al. 11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approachesBioorg Med Chem. (2010)
  95. a b Borrelli F, et al. Effect of Boswellia serrata on intestinal motility in rodents: inhibition of diarrhoea without constipationBr J Pharmacol. (2006)
  96. a b Latella G, et al. Prevention of colonic fibrosis by Boswellia and Scutellaria extracts in rats with colitis induced by 2,4,5-trinitrobenzene sulphonic acidEur J Clin Invest. (2008)
  97. ^ Ke F, Yadav PK, Ju LZ. Herbal medicine in the treatment of ulcerative colitisSaudi J Gastroenterol. (2012)
  98. a b Hartmann RM, et al. Effect of Boswellia serrata on antioxidant status in an experimental model of colitis rats induced by acetic acidDig Dis Sci. (2012)
  99. a b Anthoni C, et al. Mechanisms underlying the anti-inflammatory actions of boswellic acid derivatives in experimental colitisAm J Physiol Gastrointest Liver Physiol. (2006)
  100. ^ Rhodes JM, et al. Serum inhibitors of leukocyte chemotaxis in Crohn’s disease and ulcerative colitisGastroenterology. (1982)
  101. ^ Chande N, McDonald JW, Macdonald JK. Interventions for treating collagenous colitisCochrane Database Syst Rev. (2008)
  102. ^ Madisch A, et al. Boswellia serrata extract for the treatment of collagenous colitis. A double-blind, randomized, placebo-controlled, multicenter trialInt J Colorectal Dis. (2007)
  103. ^ Slonim AE, Grovit M, Bulone L. Effect of exclusion diet with nutraceutical therapy in juvenile Crohn’s diseaseJ Am Coll Nutr. (2009)
  104. a b c Holtmeier W, et al. Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn’s disease: good safety profile but lack of efficacyInflamm Bowel Dis. (2011)
  105. a b Raja AF, et al. Acetyl-11-keto-β-boswellic acid (AKBA); targeting oral cavity pathogensBMC Res Notes. (2011)
  106. ^ Schillaci D, et al. In vitro anti-biofilm activity of Boswellia spp. oleogum resin essential oilsLett Appl Microbiol. (2008)
  107. a b Mahmoud MF, Diaai AA, Ahmed F. Evaluation of the efficacy of ginger, Arabic gum, and Boswellia in acute and chronic renal failureRen Fail. (2012)
  108. ^ Gupta I, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical studyEur J Med Res. (1998)
  109. ^ Clark CE, et al. Herbal interventions for chronic asthma in adults and children: a systematic review and meta-analysisPrim Care Respir J. (2010)
  110. a b Houssen ME, et al. Natural anti-inflammatory products and leukotriene inhibitors as complementary therapy for bronchial asthmaClin Biochem. (2010)
  111. a b Lakka A, et al. Isolation of hypoxia-inducible factor 1 (HIF-1) inhibitors from frankincense using a molecularly imprinted polymerInvest New Drugs. (2011)
  112. ^ Wenger RH. Cellular adaptation to hypoxia: O2-sensing protein hydroxylases, hypoxia-inducible transcription factors, and O2-regulated gene expressionFASEB J. (2002)
  113. ^ Belozerov VE, Van Meir EG. Hypoxia inducible factor-1: a novel target for cancer therapyAnticancer Drugs. (2005)
  114. a b c d e f Pang X, et al. Acetyl-11-keto-beta-boswellic acid inhibits prostate tumor growth by suppressing vascular endothelial growth factor receptor 2-mediated angiogenesisCancer Res. (2009)
  115. a b c Hoernlein RF, et al. Acetyl-11-keto-beta-boswellic acid induces apoptosis in HL-60 and CCRF-CEM cells and inhibits topoisomerase IJ Pharmacol Exp Ther. (1999)
  116. ^ Castelli S, et al. Interaction between natural compounds and human topoisomerase IBiol Chem. (2012)
  117. ^ On the expression and regulation of 5-lipoxygenase in human lymphocytes.
  118. a b c d Glaser T, et al. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivityBr J Cancer. (1999)
  119. ^ Glioblastoma multiforme: Morphology and biology.
  120. a b Flavin DF. A lipoxygenase inhibitor in breast cancer brain metastasesJ Neurooncol. (2007)
  121. ^ Shen Y, et al. Boswellic acid induces epigenetic alterations by modulating DNA methylation in colorectal cancer cellsCancer Biol Ther. (2012)
  122. a b Takahashi M, et al. Boswellic acid exerts antitumor effects in colorectal cancer cells by modulating expression of the let-7 and miR-200 microRNA familyCarcinogenesis. (2012)
  123. ^ Liu JJ, Duan RD. LY294002 enhances boswellic acid-induced apoptosis in colon cancer cellsAnticancer Res. (2009)
  124. ^ Liu HP, et al. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) miceInt J Cancer. (2012)
  125. ^ Suh J, et al. Mechanisms of constitutive NF-kappaB activation in human prostate cancer cellsProstate. (2002)
  126. ^ Büchele B, et al. Characterization of 3alpha-acetyl-11-keto-alpha-boswellic acid, a pentacyclic triterpenoid inducing apoptosis in vitro and in vivoPlanta Med. (2006)
  127. ^ Lu M, et al. Acetyl-keto-beta-boswellic acid induces apoptosis through a death receptor 5-mediated pathway in prostate cancer cellsCancer Res. (2008)
  128. ^ Kim HR, et al. Bosellia serrata-induced apoptosis is related with ER stress and calcium releaseGenes Nutr. (2008)
  129. ^ Khan S, et al. A cyano analogue of boswellic acid induces crosstalk between p53/PUMA/Bax and telomerase that stages the human papillomavirus type 18 positive HeLa cells to apoptotic deathEur J Pharmacol. (2011)
  130. ^ Kaur R, et al. A comparative study of proapoptotic potential of cyano analogues of boswellic acid and 11-keto-boswellic acidEur J Med Chem. (2011)
  131. a b Aggarwal BB, et al. Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solutionAnn N Y Acad Sci. (2006)
  132. ^ Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene Expression.
  133. a b c d Kunnumakkara AB, et al. Boswellic acid blocks signal transducers and activators of transcription 3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase SHP-1Mol Cancer Res. (2009)
  134. ^ Gene Silencing of the Tyrosine Phosphatase SHP1 Gene by Aberrant Methylation in Leukemias/Lymphomas.
  135. a b c d e f g Park B, et al. Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expressionInt J Cancer. (2011)
  136. ^ Suhail MM, et al. Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cellsBMC Complement Altern Med. (2011)
  137. ^ Mothana RA, et al. Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island SoqotraBMC Complement Altern Med. (2009)
  138. ^ Koshiba T, et al. Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progressionClin Cancer Res. (2000)
  139. a b c d e Park B, et al. Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targetsPLoS One. (2011)
  140. ^ Ni X, et al. Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine modelBMC Complement Altern Med. (2012)
  141. ^ Safayhi H, Sailer ER. Anti-inflammatory actions of pentacyclic triterpenesPlanta Med. (1997)
  142. a b c Pedretti A, et al. Effects of topical boswellic acid on photo and age-damaged skin: clinical, biophysical, and echographic evaluations in a double-blind, randomized, split-face studyPlanta Med. (2010)
  143. a b Calzavara-Pinton P, et al. Topical Boswellic acids for treatment of photoaged skinDermatol Ther. (2010)
  144. a b Krishnaraju AV, et al. Safety and toxicological evaluation of Aflapin: a novel Boswellia-derived anti-inflammatory productToxicol Mech Methods. (2010)
  145. ^ Tripathi YB. BHUx: a patented polyherbal formulation to prevent hyperlipidemia and atherosclerosisRecent Pat Inflamm Allergy Drug Discov. (2009)
  146. a b c d Su S, et al. Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carteriiJ Ethnopharmacol. (2012)
  147. a b Sferra R, et al. Boswellia serrata and Salvia miltiorrhiza extracts reduce DMN-induced hepatic fibrosis in mice by TGF-beta1 downregulationEur Rev Med Pharmacol Sci. (2012)
  148. a b Lalithakumari K, et al. Safety and Toxicological Evaluation of a Novel, Standardized 3-O-Acetyl-11-keto-beta-Boswellic Acid (AKBA)-Enriched Boswellia serrata Extract (5-Loxin(R))Toxicol Mech Methods. (2006)
  149. ^ Lupi S, et al. Mutagenicity evaluation with Ames test of hydro-alcoholic solution of terpenesJ Prev Med Hyg. (2009)
  150. ^ Sharma R, et al. In vivo genotoxicity evaluation of a plant based antiarthritic and anticancer therapeutic agent Boswelic acids in rodentsPhytomedicine. (2009)
  151. ^ Acebo E, et al. Allergic contact dermatitis from Boswellia serrata extract in a naturopathic creamContact Dermatitis. (2004)